Application Note

How Droplet Digital PCR Has Revolutionized Noninvasive Plasma-Based Detection Of Mutations

Source: Bio-Rad
QX200_0029

Research Background
MolecularMD is a preferred provider of molecular diagnostic products and services to pharmaceutical and biotechnology drug developers. Our capabilities range from specialty molecular testing performed in our centralized CLIA-certified and CAP-accredited laboratories to development of FDA-approved companion diagnostics.